Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 517172, 7 pages
http://dx.doi.org/10.1155/2012/517172
Research Article

CD24 Expression as a Marker for Predicting Clinical Outcome in Human Gliomas

Department of Neurosurgery, Institute for Functional Neurosurgery PLA, TangDu Hospital, Fourth Military Medical University, No. 1 Xinsi Road, Baqiao District, Xi’an 710038, China

Received 6 November 2011; Accepted 5 December 2011

Academic Editor: Xin-yuan Guan

Copyright © 2012 Jianping Deng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Wick, M. Platten, and M. Weller, “New (alternative) temozolomide regimens for the treatment of glioma,” Neuro-Oncology, vol. 11, no. 1, pp. 69–79, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. A. L. Rivera, C. E. Pelloski, E. Sulman, and K. Aldape, “Prognostic and predictive markers in glioma and other neuroepithelial tumors,” Current Problems in Cancer, vol. 32, no. 3, pp. 97–123, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. C. Poncet, V. Frances, R. Gristina, C. Scheiner, J. F. Pellissier, and D. Figarella-Branger, “CD24, a glycosylphosphatidylinositol-anchored molecule, is transiently expressed during the development of human central nervous system and is a marker of human neural cell lineage tumors,” Acta Neuropathologica, vol. 91, no. 4, pp. 400–408, 1996. View at Google Scholar · View at Scopus
  4. J. B. Overdevest, S. Thomas, G. Kristiansen, D. E. Hansel, S. C. Smith, and D. Theodorescu, “CD24 offers a therapeutic target for control of bladder cancer metastasis based on a requirement for lung colonization,” Cancer Research, vol. 71, no. 11, pp. 3802–3811, 2011. View at Publisher · View at Google Scholar · View at PubMed
  5. K. Taniuchi, I. Nishimori, and M. A. Hollingsworth, “Intracellular CD24 inhibits cell invasion by posttranscriptional regulation of BART through interaction with G3BP,” Cancer Research, vol. 71, no. 3, pp. 895–905, 2011. View at Publisher · View at Google Scholar · View at PubMed
  6. J. H. Myung, K. A. Gajjar, R. M. Pearson, C. A. Launiere, D. T. Eddington, and S. Hong, “Direct measurements on CD24-mediated rolling of human breast cancer MCF-7 cells on E-selectin,” Analytical Chemistry, vol. 83, no. 3, pp. 1078–1083, 2011. View at Publisher · View at Google Scholar · View at PubMed
  7. M. K. Pass, G. Quintini, J. A. Zarn, S. M. Zimmermann, J. A. Sigrist, and R. A. Stahel, “The 5'-flanking region of human CD24 gene has cell-type-specific promoter activity in small-cell lung cancer,” International Journal of Cancer, vol. 78, no. 4, pp. 496–502, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Sano, H. Kato, S. Sakurai et al., “CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma,” Annals of Surgical Oncology, vol. 16, no. 2, pp. 506–514, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. L. R. Huang and H. C. Hsu, “Cloning and expression of CD24 gene in human hepatocellular carcinoma: a potential early tumor marker gene correlates with p53 mutation and tumor differentiation,” Cancer Research, vol. 55, no. 20, pp. 4717–4721, 1995. View at Google Scholar · View at Scopus
  10. Y. L. Choi, S. H. Kim, Y. K. Shin et al., “Cytoplasmic CD24 expression in advanced ovarian serous borderline tumors,” Gynecologic Oncology, vol. 97, no. 2, pp. 379–386, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. V. Senner, A. Sturm, I. Baur, U. H. M. Schrell, L. Distel, and W. Paulus, “CD24 promotes invasion of glioma cells in vivo,” Journal of Neuropathology and Experimental Neurology, vol. 58, no. 8, pp. 795–802, 1999. View at Google Scholar · View at Scopus
  12. D. N. Louis, H. Ohgaki, O. D. Wiestler et al., “The 2007 WHO classification of tumours of the central nervous system,” Acta Neuropathologica, vol. 114, no. 2, pp. 97–109, 2007. View at Publisher · View at Google Scholar · View at PubMed
  13. M. Nakada, K. L. Drake, S. Nakada, J. A. Niska, and M. E. Berens, “Ephrin-B3 ligand promotes glioma invasion through activation of Rac1,” Cancer Research, vol. 66, no. 17, pp. 8492–8500, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. R. S. Brown and R. L. Wahl, “Overexpression of Glut-1 glucose transporter in human breast cancer: an immunohistochemical study,” Cancer, vol. 72, no. 10, pp. 2979–2985, 1993. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Shapira, A. Shapira, A. Starr et al., “An immunoconjugate of Anti-CD24 and pseudomonas exotoxin selectively kills human colorectal tumors in mice,” Gastroenterology, vol. 140, no. 3, pp. 935–946, 2011. View at Publisher · View at Google Scholar · View at PubMed
  16. K. Horiguchi, M. Toi, S. I. Horiguchi et al., “Predictive value of CD24 and CD44 for neoadjuvant chemotherapy response and prognosis in primary breast cancer patients,” Journal of Medical and Dental Sciences, vol. 57, no. 2, pp. 165–175, 2010. View at Google Scholar · View at Scopus
  17. H. J. Kim, M. J. Kim, S. H. Ahn et al., “Different prognostic significance of CD24 and CD44 expression in breast cancer according to hormone receptor status,” Breast, vol. 20, pp. 78–85, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. H. J. Lee, G. Choe, S. Jheon, S. W. Sung, C. T. Lee, and J. H. Chung, “CD24, a novel cancer biomarker, predicting disease-free survival of non-small cell lung carcinomas: a retrospective study of prognostic factor analysis from the viewpoint of forthcoming (Seventh) New TNM classification,” Journal of Thoracic Oncology, vol. 5, no. 5, pp. 649–657, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. G. Kristiansen, E. MacHado, N. Bretz et al., “Molecular and clinical dissection of CD24 antibody specificity by a comprehensive comparative analysis,” Laboratory Investigation, vol. 90, no. 7, pp. 1102–1116, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. W. Wang, X. Wang, L. Peng et al., “CD24-dependent MAPK pathway activation is required for colorectal cancer cell proliferation,” Cancer Science, vol. 101, no. 1, pp. 112–119, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. D. Su, H. Deng, X. Zhao et al., “Targeting CD24 for treatment of ovarian cancer by short hairpin RNA,” Cytotherapy, vol. 11, no. 5, pp. 642–652, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. G. Kristiansen, K. Schlüns, Y. Yongwei, C. Denkert, M. Dietel, and I. Petersen, “CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients,” British Journal of Cancer, vol. 88, no. 2, pp. 231–236, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. P. Athanassiadou, D. Grapsa, M. Gonidi, A. M. Athanassiadou, A. Tsipis, and E. Patsouris, “CD24 expression has a prognostic impact in breast carcinoma,” Pathology Research and Practice, vol. 205, no. 8, pp. 524–533, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. M. C. Su, C. Hsu, H. L. Kao, and Y. M. Jeng, “CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma,” Cancer Letters, vol. 235, no. 1, pp. 34–39, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. X. R. Yang, Y. Xu, B. Yu et al., “CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery,” Clinical Cancer Research, vol. 15, no. 17, pp. 5518–5527, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. E. Sagiv and N. Arber, “The novel oncogene CD24 and its arising role in the carcinogenesis of the GI tract: from research to therapy,” Expert Review of Gastroenterology and Hepatology, vol. 2, no. 1, pp. 125–133, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. M. Fèvre-Montange, J. Champier, A. Szathmari et al., “Microarray analysis reveals differential gene expression patterns in tumors of the pineal region,” Journal of Neuropathology and Experimental Neurology, vol. 65, no. 7, pp. 675–684, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. H. W. Lo, H. Zhu, X. Cao, A. Aldrich, and F. Ali-Osman, “A novel splice variant of GLI1 that promotes glioblastoma cell migration and invasion,” Cancer Research, vol. 69, no. 17, pp. 6790–6798, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus